Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Receivables (2018 - 2025)

Historic Receivables for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $11.3 million.

  • Bio's Receivables rose 46.34% to $11.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.3 million, marking a year-over-year increase of 46.34%. This contributed to the annual value of $10.1 million for FY2024, which is 370.75% up from last year.
  • Per Bio's latest filing, its Receivables stood at $11.3 million for Q3 2025, which was up 46.34% from $11.2 million recorded in Q2 2025.
  • In the past 5 years, Bio's Receivables registered a high of $11.3 million during Q3 2025, and its lowest value of $2.8 million during Q1 2021.
  • For the 5-year period, Bio's Receivables averaged around $7.5 million, with its median value being $7.9 million (2023).
  • Per our database at Business Quant, Bio's Receivables skyrocketed by 5919.4% in 2022 and then soared by 46.34% in 2025.
  • Over the past 5 years, Bio's Receivables (Quarter) stood at $4.2 million in 2021, then skyrocketed by 56.38% to $6.6 million in 2022, then surged by 47.06% to $9.7 million in 2023, then rose by 3.71% to $10.1 million in 2024, then grew by 11.65% to $11.3 million in 2025.
  • Its Receivables stands at $11.3 million for Q3 2025, versus $11.2 million for Q2 2025 and $10.6 million for Q1 2025.